EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin

Guanglong Ma, Andrew R Crowley, Liesbeth Heyndrickx, Ilse Rogiers, Eef Parthoens, Jolien Van Santbergen, Raimund J Ober, Vladimir Bobkov, Hans de Haard, Peter Ulrichts, Erik Hofman, Els Louagie und 2 weitere

JCI Insight · 22.05.2024 · 9 (10)

DOI: 10.1172/jci.insight.176166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 07.05.2024. Verfasst von Guanglong Ma und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. Hauptthemen laut MEDLINE: Receptors, Fc, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The homeostasis of IgG is maintained by the neonatal Fc receptor, FcRn. Consequently, antagonism of FcRn to reduce endogenous IgG levels is an emerging strategy for treating antibody-mediated autoimmune disorders using either FcRn-specific antibodies or an engineered Fc fragment. For certain FcRn-specific antibodies, this approach has resulted in reductions in the levels of serum albumin, the other major ligand transported by FcRn. Cellular and molecular analyses of a panel of FcRn antagonists have been carried out to elucidate the mechanisms leading to their differential effects on albumin homeostasis. These analyses have identified 2 processes underlying decreases in albumin levels during FcRn blockade: increased degradation of FcRn and competition between antagonist and albumin for FcRn binding. These findings have potential implications for the design of drugs to modulate FcRn function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, FcHistocompatibility Antigens Class IHumansImmunoglobulin GAnimalsProtein TransportSerum AlbuminMiceProtein Binding

Stichwörter der Autor:innen

Autoimmune diseasesAutoimmunityImmunoglobulinsImmunology

Substanzen

Receptors, FcHistocompatibility Antigens Class IImmunoglobulin GSerum AlbuminFc receptor, neonatal

Autor:innen und Institutionen

  • Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • argenx, Zwijnaarde, Ghent, Belgium.
  • VIB BioImaging Core, Center for Inflammation Research, Ghent, Belgium.

Förderung

  • Medical Research Council

Zitieren

APA

Ma, G., Crowley, A. R., Heyndrickx, L., Rogiers, I., Parthoens, E., Van Santbergen, J., Ober, R. J., Bobkov, V., de Haard, H., Ulrichts, P., Hofman, E., Louagie, E., Balbino, B., & Ward, E. S. (2024). Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin. JCI Insight, 9(10). https://doi.org/10.1172/jci.insight.176166

Vancouver

Ma G, Crowley AR, Heyndrickx L, Rogiers I, Parthoens E, Van Santbergen J, et al. Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin. JCI Insight. 2024;9(10). doi:10.1172/jci.insight.176166

BibTeX
@article{Ma2024,
  author = {Ma, Guanglong and Crowley, Andrew R and Heyndrickx, Liesbeth and Rogiers, Ilse and Parthoens, Eef and Van Santbergen, Jolien and Ober, Raimund J and Bobkov, Vladimir and de Haard, Hans and Ulrichts, Peter and Hofman, Erik and Louagie, Els and Balbino, Bianca and Ward, E Sally},
  title = {Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin},
  journal = {JCI Insight},
  year = {2024},
  volume = {9},
  number = {10},
  doi = {10.1172/jci.insight.176166}
}
Kostenlos starten →